Santhera Pharmaceuticals (Schweiz) AG

Pharmaceutical preparations for the treatment of neuromuscular diseases, but not in the field of oncology and rheumatoid arthritis

Pharmaceutical preparations for the treatment of ocular, inflammatory and pulmonary diseases, but not in the field of oncology and rheumatoid arthritis

Pharmaceutical preparations for the treatment of neuromuscular and inflammatory diseases

Pharmaceutical preparations for the treatment of muscular dystrophy, muscular atrophy, metabolic diseases, neuromuscular diseases, respiratory diseases and ophthalmic diseases; Services in the field of scientific and industrial research, namely, the development of data processing programs for these purposes, in particular in the fields of cell cultures, cellular test systems for the evaluation of drugs, antibodies, test systems for the detection of pharmacologically active compounds, animal models for metabolic, neuromuscular, respiratory and ophthalmic diseases

chemicals used in industry and science | pharmaceutical, veterinary and sanitary preparations, namely, chemical preparations for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss | computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific re-search for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases, scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss